A detailed history of Harbor Group, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Harbor Group, Inc. holds 1,671 shares of JNJ stock, worth $259,071. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,671
Previous 1,670 0.06%
Holding current value
$259,071
Previous $244,000 10.66%
% of portfolio
0.06%
Previous 0.06%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$145.48 - $167.38 $145 - $167
1 Added 0.06%
1,671 $270,000
Q2 2024

Jul 12, 2024

SELL
$144.38 - $157.78 $9,240 - $10,097
-64 Reduced 3.69%
1,670 $244,000
Q1 2024

Apr 15, 2024

BUY
$155.22 - $162.74 $155 - $162
1 Added 0.06%
1,734 $274,000
Q4 2023

Jan 10, 2024

SELL
$145.6 - $158.88 $2,038 - $2,224
-14 Reduced 0.8%
1,733 $271,000
Q3 2023

Oct 10, 2023

SELL
$155.75 - $174.48 $16,821 - $18,843
-108 Reduced 5.82%
1,747 $272,000
Q2 2023

Jul 13, 2023

SELL
$154.35 - $166.11 $71,464 - $76,908
-463 Reduced 19.97%
1,855 $307,000
Q1 2023

Apr 11, 2023

BUY
$151.05 - $180.26 $98,484 - $117,529
652 Added 39.14%
2,318 $359,000
Q4 2022

Jan 19, 2023

BUY
$160.2 - $179.79 $320 - $359
2 Added 0.12%
1,666 $0
Q3 2022

Oct 12, 2022

BUY
$161.33 - $179.52 $322 - $359
2 Added 0.12%
1,664 $272,000
Q2 2022

Jul 15, 2022

SELL
$168.19 - $186.01 $10,932 - $12,090
-65 Reduced 3.76%
1,662 $295,000
Q1 2022

Apr 25, 2022

BUY
$158.14 - $179.59 $19,767 - $22,448
125 Added 7.8%
1,727 $306,000
Q4 2021

Jan 25, 2022

BUY
$155.93 - $173.01 $311 - $346
2 Added 0.13%
1,602 $274,000
Q3 2021

Oct 19, 2021

SELL
$161.5 - $179.47 $4,522 - $5,025
-28 Reduced 1.72%
1,600 $258,000
Q2 2021

Jul 26, 2021

BUY
$159.48 - $171.07 $318 - $342
2 Added 0.12%
1,628 $268,000
Q1 2021

Apr 23, 2021

BUY
$153.07 - $170.48 $2,908 - $3,239
19 Added 1.18%
1,626 $269,000
Q4 2020

Jan 21, 2021

BUY
$137.11 - $157.38 $220,335 - $252,909
1,607 New
1,607 $254,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Harbor Group, Inc. Portfolio

Follow Harbor Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Group, Inc. with notifications on news.